CERETYPE NEUROMEDICINE IN

Medtech · Private

End-to-end advanced fMRI platform with standardized processing and artifact reduction for clinical neuropsychiatric trials

Grants
$380K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Design and Development of an Advanced Functional MRI Software as Medical Device (SaMD) forClinical Trials and Therapeutic Applications in Neuropsychiatry$380,375
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2123MOBIUS BIOTECH LLC——
2124YELLOWSTONE SCIENTIFIC INSTRUMENTS——
2125DELTAMED LLC——
2126CERETYPE NEUROMEDICINE IN——
2127Hays, Inc.——
2128GENASSIST INC——
2129PREHAB TECHNOLOGIES, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.